Workflow
Aldeyra Therapeutics(ALDX) - 2025 FY - Earnings Call Transcript

Aldeyra Therapeutics (ALDX) FY 2025 Conference February 11, 2025 09:20 AM ET Company Participants Todd Brady - CEO, President & Director Conference Call Participants François Brisebois - Managing Director, Senior Biotechnology Research Analyst François Brisebois Alright. Great. Thank you for joining. My name is Frank Breasbois. I'm one of the biotech analysts at Oppenheimer. Our next presenting company here is Aldara Therapeutics. From the company, we have CEO, Todd Brady, to join. I think what we're going ...